Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Peripheral Immune System and Amyotrophic Lateral Sclerosis
Pamela McCombe, John D. Lee, Trent M. Woodruff, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions
Suganya Kanmani, Byung‐Soo Koo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7551-7551
Open Access | Times Cited: 235
Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle
Saravana Babu Chidambaram, Musthafa Mohamed Essa, Annan Gopinath Rathipriya, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107988-107988
Open Access | Times Cited: 121
Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk
Austin P. Passaro, Abraham L. Lebos, Yao Yao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 76
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS
Paul J. Hop, Ramona A.J. Zwamborn, Eilís Hannon, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 633
Open Access | Times Cited: 66
Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis
Kim A. Staats, David Borchelt, Malú G. Tansey, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 51
Impaired glymphatic function in the early stages of disease in a TDP-43 mouse model of amyotrophic lateral sclerosis
Akram Zamani, Adam K. Walker, Ben Rollo, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 43
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
Jessica Mandrioli, Roberto D’Amico, Elisabetta Zucchi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Peripheral Glycolysis in Neurodegenerative Diseases
Simon Bell, Toby Burgess, James Lee, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 8924-8924
Open Access | Times Cited: 58
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration
Stanley H. Appel, David R. Beers, Weihua Zhao
Current Opinion in Neurology (2021) Vol. 34, Iss. 5, pp. 765-772
Closed Access | Times Cited: 55
Genetic background variation impacts microglial heterogeneity and disease progression in amyotrophic lateral sclerosis model mice
Okiru Komine, Syuhei Ohnuma, Kunihiko Hinohara, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108872-108872
Open Access | Times Cited: 6
Dietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites
Dulce M. Frausto, Christopher B. Forsyth, Ali Keshavarzian, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 40
Delayed Onset Muscle Soreness (DOMS): The Repeated Bout Effect and Chemotherapy-Induced Axonopathy May Help Explain the Dying-Back Mechanism in Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases
Balázs Sonkodi
Brain Sciences (2021) Vol. 11, Iss. 1, pp. 108-108
Open Access | Times Cited: 36
Neuroimmune Crosstalk Between the Peripheral and the Central Immune System in Amyotrophic Lateral Sclerosis
Weiyi Yu, Ji He, Xiying Cai, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 25
Tissue informative cell-free DNA methylation sites in amyotrophic lateral sclerosis
Christa Caggiano, Marco Morselli, Xia Qian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
Kiterie M. E. Faller, Helena Chaytow, Thomas H. Gillingwater
Nature Reviews Neurology (2025) Vol. 21, Iss. 2, pp. 86-102
Closed Access
A molecular systems architecture of neuromuscular junction in amyotrophic lateral sclerosis
V. A. Shiva Ayyadurai, Prabhakar Deonikar, Roger D. Kamm
npj Systems Biology and Applications (2025) Vol. 11, Iss. 1
Open Access
The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy
Megan Dubowsky, Frances Theunissen, Jillian M. Carr, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6330-6345
Open Access | Times Cited: 11
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules
Elena Niccolai, Matteo Pedone, Ilaria Martinelli, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 4310-4325
Open Access | Times Cited: 4
Cortical thickness correlated with peripheral inflammatory cytokines in amyotrophic lateral sclerosis
Jing Yang, Wenyi Li, Mei Tian, et al.
Frontiers in Neuroscience (2025) Vol. 18
Open Access
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2
Ilaria Giovannelli, Nadhim Bayatti, A.G. Brown, et al.
Brain Communications (2021) Vol. 3, Iss. 3
Open Access | Times Cited: 24
Peripheral Immune Profiles Predict ALS Progression in an Age- and Sex-Dependent Manner
Benjamin J. Murdock, Bangyao Zhao, Kristen D. Pawlowski, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 11, Iss. 3
Open Access | Times Cited: 3
Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
John D. Lee, Tanya S. McDonald, Jenny N. Fung, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 10, pp. 4143-4155
Open Access | Times Cited: 26
Natural killer cells-related immune traits and amyotrophic lateral sclerosis: A Mendelian randomization study
Zhenxiang Gong, Yang Liu, Fengfei Ding, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 15
Circulating NAD+ Metabolism-Derived Genes Unveils Prognostic and Peripheral Immune Infiltration in Amyotrophic Lateral Sclerosis
Cheng Li, Yu Zhu, Wenzhi Chen, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 14
Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis
Abdelilah Assialioui, Raúl Domínguez, Isidró Ferrer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11063-11063
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top